O-acyl isopeptide method: development of an O-acyl isodipeptide unit for Boc SPPS and its application to the synthesis of Aβ1-42 isopeptide. 2014

Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
Peptide Institute, Inc., Osaka, 567-0085, Japan.

The O-acyl isopeptide method was developed for the efficient preparation of difficult sequence-containing peptide. Furthermore, development of the O-acyl isodipeptide unit for Fmoc chemistry simplified its synthetic procedure by solid-phase peptide synthesis. Here, we report a novel isodipeptide unit for Boc chemistry, and the unit was successfully applied to the synthesis of amyloid β peptide. Combination of Boc chemistry and the isodipeptide unit would be an effective method for the synthesis of many difficult peptides. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D058228 Islet Amyloid Polypeptide A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS. Amlintide,Amylin,IAPP Precursor,IAPP Protein,Insulinoma Amyloid Polypeptide,Insulinoma Amyloid Polypeptide Precursor,Islet Amyloid Polypeptide Precursor,Pancreatic Amylin,Amylin, Pancreatic,Amyloid Polypeptide, Insulinoma,Amyloid Polypeptide, Islet,Polypeptide, Insulinoma Amyloid,Polypeptide, Islet Amyloid
D060327 Solid-Phase Synthesis Techniques Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps. Solid-Phase Synthesis,Peptide Synthesis, Solid-Phase,Solid-Phase Nucleotide Synthesis,Solid-Phase Nucleotide Synthesis Techniques,Solid-Phase Peptide Synthesis,Solid-Phase Peptide Synthesis Techniques,Solid-Phase Synthesis Methods,Synthesis, Solid-Phase,Method, Solid-Phase Synthesis,Methods, Solid-Phase Synthesis,Nucleotide Syntheses, Solid-Phase,Nucleotide Synthesis, Solid-Phase,Peptide Syntheses, Solid-Phase,Peptide Synthesis, Solid Phase,Solid Phase Nucleotide Synthesis,Solid Phase Nucleotide Synthesis Techniques,Solid Phase Peptide Synthesis,Solid Phase Peptide Synthesis Techniques,Solid Phase Synthesis,Solid Phase Synthesis Methods,Solid Phase Synthesis Techniques,Solid-Phase Nucleotide Syntheses,Solid-Phase Peptide Syntheses,Solid-Phase Syntheses,Solid-Phase Synthesis Method,Solid-Phase Synthesis Technique,Syntheses, Solid-Phase,Syntheses, Solid-Phase Nucleotide,Syntheses, Solid-Phase Peptide,Synthesis Method, Solid-Phase,Synthesis Methods, Solid-Phase,Synthesis Technique, Solid-Phase,Synthesis Techniques, Solid-Phase,Synthesis, Solid Phase,Synthesis, Solid-Phase Nucleotide,Synthesis, Solid-Phase Peptide,Technique, Solid-Phase Synthesis,Techniques, Solid-Phase Synthesis

Related Publications

Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
December 2007, Journal of peptide science : an official publication of the European Peptide Society,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
June 2007, Organic & biomolecular chemistry,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
January 2007, Biopolymers,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
July 2009, Organic & biomolecular chemistry,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
August 2011, Protein and peptide letters,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
January 2016, Organic letters,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
November 2008, Journal of peptide science : an official publication of the European Peptide Society,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
July 2005, Journal of peptide science : an official publication of the European Peptide Society,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
November 2005, Bioorganic & medicinal chemistry,
Taku Yoshiya, and Tsuyoshi Uemura, and Takahiro Maruno, and Shigeru Kubo, and Yoshiaki Kiso, and Youhei Sohma, and Yuji Kobayashi, and Kumiko Yoshizawa-Kumagaye, and Yuji Nishiuchi
March 2013, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!